Literature DB >> 24846345

Body composition affects the response to erythropoiesis-stimulating agents in patients with chronic kidney disease in dialysis.

Almudena Vega1, Caridad Ruiz, Soraya Abad, Borja Quiroga, Kyra Velázquez, Claudia Yuste, Inés Aragoncillo, Juan Manuel López Gómez.   

Abstract

BACKGROUND: The response to erythropoiesis-stimulating agents (ESA) in patients with chronic kidney disease (CKD) is variable. The body mass index (BMI) variations can modify the response to ESA. The objective was to assess the effect of body composition on the response to ESA in dialysis patients.
METHODS: This is an observational cross-sectional study. Prevalent hemodialysis and peritoneal dialysis (PD) patients were selected. In the same day, a single blood test, a body composition analysis using bioimpedance spectroscopy and anthropometric measurements were performed. We collected ESA doses. We analyzed erythropoietin resistance index (ERI). The ERI was calculated dividing the weekly weight-adjusted (kg) dose of ESA (IU) by the hemoglobin level (g/dL).
RESULTS: The study was comprised of 218 patients (58% men; age 65 (16) years old; 80% hemodialysis, 20% PD). There was an inverse correlation between ERI and BMI (p=0.01), fat tissue index (FTI) (p=0.01) and prealbumin (p=0.04). We found an independent association between higher ERI levels and lower FTI and prealbumin values.
CONCLUSION: Response to ESA is influenced by body composition. Fat tissue favors the body's response to ESA.

Entities:  

Keywords:  Anemia; bioimpedance spectroscopy; fat tissue

Mesh:

Substances:

Year:  2014        PMID: 24846345     DOI: 10.3109/0886022X.2014.917937

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  9 in total

1.  How Is Body Composition and Nutrition Status Associated with Erythropoietin Response in Hemodialyzed Patients? A Single-Center Prospective Cohort Study.

Authors:  Wiktoria Feret; Krzysztof Safranow; Kazimierz Ciechanowski; Ewa Kwiatkowska
Journal:  J Clin Med       Date:  2022-04-26       Impact factor: 4.964

2.  Investigation of the Relationship between Lean Muscle Mass and Erythropoietin Resistance in Maintenance Haemodialysis Patients: A Cross-Sectional Study.

Authors:  Wen-Fang Chiang; Po-Jen Hsiao; Kun-Lin Wu; Hung-Ming Chen; Chi-Ming Chu; Jenq-Shyong Chan
Journal:  Int J Environ Res Public Health       Date:  2022-05-07       Impact factor: 4.614

3.  Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients.

Authors:  Matthew B Rivara; T Alp Ikizler; Charles D Ellis; Rajnish Mehrotra; Jonathan Himmelfarb
Journal:  BMC Nephrol       Date:  2015-06-05       Impact factor: 2.388

Review 4.  Effect of peritoneal dialysis versus hemodialysis on renal anemia in renal in end-stage disease patients: a meta-analysis.

Authors:  Wan-Ning Wang; Wen-Long Zhang; Tao Sun; Fu-Zhe Ma; Sensen Su; Zhong-Gao Xu
Journal:  Ren Fail       Date:  2016-11-17       Impact factor: 2.606

5.  Obesity may be erythropoietin dose-saving in hemodialysis patients.

Authors:  Ghada M El-Kannishy; Abir F Megahed; Mona M Tawfik; Ghada El-Said; Rabab T Zakaria; Nahed A Mohamed; Eman M Taha; Alzhraa A Ammar; Abeer M Abd Eltawab; Nagy A Sayed-Ahmed
Journal:  Kidney Res Clin Pract       Date:  2018-06-30

6.  Relationship between protein-energy wasting in adults with chronic hemodialysis and the response to treatment with erythropoietin.

Authors:  Ailema González-Ortiz; Ricardo Correa-Rotter; Armando Vázquez-Rangel; Olynka Vega-Vega; Ángeles Espinosa-Cuevas
Journal:  BMC Nephrol       Date:  2019-08-14       Impact factor: 2.388

7.  Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients.

Authors:  Myoung Nam Bae; Su Hyun Kim; Young Ok Kim; Dong Chan Jin; Ho Chul Song; Euy Jin Choi; Yong-Lim Kim; Yon-Su Kim; Shin-Wook Kang; Nam-Ho Kim; Chul Woo Yang; Yong Kyun Kim
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

8.  Factors Contributing to Erythropoietin Hyporesponsiveness in Patients on Long-Term Continuous Ambulatory Peritoneal Dialysis: A Cross-Sectional Study.

Authors:  Takashi Hara; Hideyuki Mukai; Takafumi Nakashima; Rikako Sagara; Masahide Furusho; Shuhei Miura; Jiro Toyonaga; Koji Sugawara; Kazuhito Takeda
Journal:  Nephron Extra       Date:  2015-10-28

9.  Use of erythropoiesis-stimulating agents in obese hemodialysis patients.

Authors:  Sun-Hee Park
Journal:  Kidney Res Clin Pract       Date:  2018-09-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.